Evvy

About:

Evvy develops at-home vaginal microbiome tests using metagenomic sequencing to understand symptoms and risks for critical health challenges.

Website: https://www.evvy.com/

Twitter/X: evvybio

Top Investors: General Catalyst, BoxGroup, Left Lane Capital, Ingeborg Investments, BBG Ventures

Description:

Evvy is a developer of at-home vaginal microbiome tests to close the gender health gap and improve female health. It uses metagenomic sequencing to understand symptoms and risks for critical health challenges, and get personalized reports.

Total Funding Amount:

$19M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

New York, New York, United States

Founded Date:

2020-01-01

Founders:

Laine Bruzek, Pita Navarro, Priyanka Jain

Number of Employees:

11-50

Last Funding Date:

2023-09-27

IPO Status:

Private

Industries:

© 2025 bioDAO.ai